Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: An overview

Clinical Infectious Diseases

Volumn 18, Issue , 1994, Pages S197-S204

  Nelson, Steve ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPICILLIN; ANTIBIOTIC AGENT; COLONY STIMULATING FACTOR RECEPTOR; ENDOTOXIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 1; LYSOSOME ENZYME; MESSENGER RNA; OXYGEN RADICAL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; BURN; DRUG EFFICACY; GRANULOPOIESIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LEUKOCYTE COUNT; MACROPHAGE; MORTALITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NOTE; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL RATE;

ACUTE DISEASE; ANIMAL; BACTERIAL INFECTIONS; CLINICAL TRIALS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMAN; MICE; NEUTROPHILS; PNEUMONIA; RATS;

EID: 0028047546     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/18.Supplement_2.S197     Document Type: Article

References (61)

1. Golde DW, Groopmen JE. Production, distribution, and fate of monocytes and macrophages. In: Williams NJ, Beutler E, Erselev AJ, Lichtman MA, eds. Hematology. New York: McGraw-Hill, 1990: 874-8.
2. Weisbart RH, Gasson JC, Golde DW. Colony-stimulating factors and host defense. Ann Intern Med 1989; 110:297-303.
3. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986:232:61-5.
4. Hammond WP, Csiba E, Canin A, et al. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest 1991;87:704-10.
5. Sheridan JW, Metcalf D. Studies on the bone marrow colony stimulating factor (CSF): relation of tissue CSF to serum CSF. J Cell Physiol 1972;80:129-40.
6. Metcalf D. Sources and biology of regulatory factors active on mousemyeloid leukemic cells. J Cell Physiol Suppl 1982;1:175-83.
7. Seelentag WK, Mermod JJ, Montesano R, Vassalli P. Additive effects of interleukin-1 and tumor necrosis factor-a on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J 1987;6:2261-5.
8. Zsebo KM, Yuschenkoff VN, Schiffer S, et al. Vascular endothelial cells and granulopoiesis: interleukin-l stimulates release of G-CSF and GM-CSF. Blood 1988;73:99-103.
9. Koeffler HP, Gasson J, Ranyard J, Souza L, Shephard M, Munker R.Recombinant human TNFa stimulates production of granulocyte colony-stimulating factor. Blood 1987;70:55-9.
10. Yang YC, Tsai S, Wong G, Clark S. Interleukin-l regulation of hematopoietic growth factor production by human stromal fibroblasts. J Cell Physiol 1988;134:292-6.
11. Metcalf D, Nicola NA. Synthesis by mouse peritoneal cells of G-CSF, the differentiation inducer for myeloid leukemia cells: stimulation by endotoxin, M-CSF and multi-CSF. Leuk Res 1985;9:35-50.
12. Rambaldi A, Young DC, Griffin JD. Expression of the M-CSF (CSF-1)gene by human monocytes. Blood 1987;69:1409-13.
13. Febbe WE, van Damme J, Billiau A, et al. Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 1988;71:430-5.
14. Rennick D, Yang G, Gemmell L, Lee F. Control of hemopoiesis by abone marrow stromal cell clone: lipopolysaccharide and interleukin-1-inducible production of colony-stimulating factors GM-CSF and G-CSF. Blood 1987:69:682-91.
15. Cheers C. Haigh AM, Kelso A. Metcalf D, Stanley ER, Young AM.Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect Immun 1988;56:247-51.
16. Nicola NA, Metcalf D. Biochemical properties of differentiation factors for murine myelomonocytic leukemic cells in organ conditioned media. Separation from colony-stimulating factors. J Cell Physiol 1981:112:257-64.
17. Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989; 73:117-22.
18. Kawakami M, Tsutsumi H, Kumakawa T, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 1990:76:1962-4.
19. Nelson S, Bagby GJ, Bainton BG, Wilson LA. Thompson JJ. Summer WR. Compartmentalization of intraalveolar and systemic lipopoly-saccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989; 159:189-94.
20. Toews GB. Determinants of bacterial clearance from the lower respiratory tract. Semin Respir Infect 1986;1:68-78.
21. Green GM, Jakab GJ, Low RB, Davis GS. Defense mechanisms of the respiratory membrane. Am Rev Respir Dis 1977; 115:479-514.
22. Tazi A, Nioche S, Chastre J, Smiejan JM, Hance AJ. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and exotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol 1991:4:140-7.
23. Tanaka H, Kaneko T. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Drug Metab Dispos 1991:19:200-4.
24. Nelson S, Bagby G, Andersen J, Shellito J, Summer W. Intratracheal granulocyte colony-stimulating factor enhances systemic and pulmonary host defenses [abstract]. Am Rev Respir Dis 1991; 143S:398.
25. Nagata S, Fukunaga R. Granulocyte colony-stimulating factor and its receptor. Prog Growth Factor Res 1991;3:131-41.
26. Fukunaga R, Ishizaka-lkeda E, Nagata S. Purification and characterization of the receptor for murine granulocyte colony-stimulating factor. J Biol Chem 1990:265:14008-15.
27. Begley CG, Lopez AF, Nicola NA, et al. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro; a rapid and sensitive microassay for colony-stimulating factors. Blood 1986:68:162-6.
28. Lindemann A, Herrmann F, Oster W, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989:74:2644-51.
29. Cohen AM, Hines DK, Korach ES, Ratzkin BJ. In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infect Immun 1988;56:2861-5.
30. Dcitch BA, Gelder F, McDonald JC. Sequential prospective analysis of the nonspecific host defense system after thermal injury. Arch Surg 1984:119:83-9.
31. Nelson R, Hasslen SR, Ahrenholz DH, Solem LD. Mechanisms of loss of human neutrophil chemotaxis following thermal injury. J Burn Care Rehabil 1987:8:496-502.
32. Sartorelli KH, Silver GM, Gamelli RL. The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis. J Trauma 1991;31:523-30.
33. Platzer E, Oez S, Welte K, et al. Human pluripotent hematopoietic colony stimulating factor: activities on human and murine cells. Immunobiology 1986:172:185-93.
34. Weisbart RH, Kacena A, Schuh A, Golde DW. GM-CSF induces human neutrophil IgA-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature 1988;332:647-8.
35. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991:163: 579-83.
36. Dobke MK, Deitch EA, Harnar TJ, Baxter CR. Oxidative activity of polymorphonuclear leukocytes after thermal injury. Arch Surg 1989;124:856-9.
37. McEuen DD. Ogawa M. Eurenius K. Myelopoiesis in the infected burn. J Lab Clin Med 1977;89:540-3.
38. Newsome TW, Eurenius K. Suppression of granulocyte and platelet production by Pseudomonas burn wound infection. Surg Gynecol Obstet 1973:136:375-9.
39. Nelson S. The effects of thermal injury on systemic and pulmonary host defenses. Critical Care Report 1991;2:241-53.
40. Mooney DP, Gamelli RL. O'Reilly M, Hebert JC. Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg 1988:123:1353-7.
41. Silver GM, Gamelli RL, O’Reilly M. The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 1989;106:452-6.
42. Yasuda H, Ajiki Y, Shimozato T, et al. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun 1990;58:2502-9.
43. Christensen RD, Harper TE, Rothstein G. Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr 1986:109: 1047-51.
44. Cairo MS, Mauss D. Kommareddy S, Norris K, Van de Ven C, Modan-lou H. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res 1990;27:612-6.
45. O'Reilly M. Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 1992;33:679-82.
46. Bagby GJ, Plessala KJ. Wilson LA, Thompson JJ, Nelson S. Divergent efficacy of antibody to tumor necrosis factor- α in intravascular and peritonitis models of sepsis. J Infect Dis 1991:163:83-8.
47. Gopal V, Bisno AL. Fulminant pneumococcal infection in “normal"asplenic hosts. Arch Intern Med 1977;137:1526-30.
48. Hebert JC, O’Reilly M, Gamelli RL. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 1990;125:1075-8.
49. Kolb D, Gunderson EKE. Alcohol-related morbidity among older career navy men. Drug Alcohol Depend 1982;9:181-9.
50. Capps JA, Coleman GH. Influence of alcohol on prognosis of pneumonia in Cook County Hospital. JAMA 1923;80:750-2.
51. MacGregor RR, Saflbrd M, Shalit M. Effect of ethanol on functions required for the delivery of neutrophils to sites of inflammation. J Infect Dis 1988;157:682-9.
52. MacGregor RR, Gluckman SG. Effect of acute alcohol intoxication on granulocyte mobilization and kinetics. Blood 1979;52:551-9.
53. Nelson S, Summer W, Bagby G, et al. Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 1991;164:901-6.
54. Antman KS, Griffin JD, Elias A, et al. Effect of recombinant human granulocyte-macrophage colony stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 1988;319:593-8.
55. Bar MH, Aronson FR. Recombinant human GM-CSF in myelosuppres-sion of chemotherapy [letter], N Engl J Med 1989;320:939-40.
56. Heidenreich S, Gong J-H, Schmidt A, Nain M, Diethard G. Macro phage activation by granulocyte/macrophage colony-stimulating factor. J Immunol 1989;143:1198-205.
57. Nelson S, Mason C, Bagby G, Andersen J, Summer WR. Effect of murine recombinant granulocyte-macrophage colony-stimulating factor on lipopolysaccharide-induced tumor necrosis factor [abstract], Am Rev Respir Dis 1990; 141S:677.
58. Havill AM, Andersen JW, Korach E, Nelson S. Enhancement ofendo-toxin-induced lethality in the mouse by GM-CSF [abstract]. Am Rev Respir Dis 1991;143S:236.
59. Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, Yokoyama T. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1992;145:1030-5.
60. Fink MR, O'Sullivan BP, Menconi MJ, et al. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993;34:571-8.
61. Van Eeden SF, Coetzee AR, Joubert JR. Community-acquired pneumonia-factors influencing intensive care admission. S Afr Med J 1988;73:77-81.